Aaron Kaplan, MD
Interventional Cardiology · Lebanon, NHNPI 1881621100
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $10,421 of the $13,365 with a category attached, or 78.0%. Tryton Medical, Inc. accounts for 78.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $10,486 and has fallen 84.8% since, to $1,592 in 2025.
Across 36 payments — averaging $371.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tryton Medical, Inc.$10K
- Abbott$1K
- Edwards Lifesciences$780
- Biosense Webster, Inc.$341
- Biotronik Inc.$239
- Boston Scientific$151
- plus $182 from 4 others
Across 84 payments — averaging $2438.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$112K
- Abbott$76K
- Gentuity, LLC$17K
What the payments were for
- Consulting fees$10,42178%
- Travel & lodging$9047%
- Food & beverage$2,04115%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tryton Medical, Inc. | 1 | $10,421 |
| Abbott | 12 | $1,252 |
| Edwards Lifesciences | 8 | $780 |
| Biosense Webster, Inc. | 5 | $341 |
| Biotronik Inc. | 2 | $239 |
| Boston Scientific | 4 | $151 |
| Philips North America LLC | 1 | $78 |
| Cardiovascular Systems Inc. | 1 | $44 |
| Shockwave Medical, Inc | 1 | $32 |
| Johnson & Johnson | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tryton Side Branch Stent$10,421
- AMPLATZER$548
- ENSITE$337
- Carto 3$263
How this compares
$13,365 in reported general payments places this provider in the 65th percentile of 26 interventional cardiology providers in New Hampshire.
See all interventional cardiology providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $11,040 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Lebanon
- Hannah ChaudryLebanon$20K
- Eric RothsteinLebanon$20K
- James DevriesLebanon$19K
- Bruce FriedmanLebanon$1K
- Alina RobertLebanon$1K
- John JayneLebanon$96
- John RobbLebanon$0
- Shahab MoossaviConcord$36K
- Nitish SharmaDover$23K
- Rodrigo Mendirichaga MaganaDover$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.